{
  "id": "642f49db57b1c7a315000014",
  "type": "list",
  "question": "List the luciferase substrates",
  "ideal_answer": "luciferase substrates include coelenterazine (CTZ), Luciferin, ATP, FMNH2, and luciferin analogs like AL3 ((S,E)-2-(6-hydroxy-5-(3-methoxy-3-oxoprop-1-en-1-yl)benzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylic acid), AL4 ((S,E)-2-(5-(2-cyanovinyl)-6-hydroxybenzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylic acid) and AL2 ((S,E)-2-(6-hydroxy-7-(3-methoxy-3-oxoprop-1-en-1-yl)benzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylic acid) as well as long-chain aldehydes--decanal (C10), dodecanal (C12) and tetradecanal (C14)]",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/11512142",
    "http://www.ncbi.nlm.nih.gov/pubmed/31764924",
    "http://www.ncbi.nlm.nih.gov/pubmed/15165512",
    "http://www.ncbi.nlm.nih.gov/pubmed/35551298",
    "http://www.ncbi.nlm.nih.gov/pubmed/25525906",
    "http://www.ncbi.nlm.nih.gov/pubmed/2230665",
    "http://www.ncbi.nlm.nih.gov/pubmed/836795",
    "http://www.ncbi.nlm.nih.gov/pubmed/34887255",
    "http://www.ncbi.nlm.nih.gov/pubmed/22789175",
    "http://www.ncbi.nlm.nih.gov/pubmed/30979501",
    "http://www.ncbi.nlm.nih.gov/pubmed/17994900",
    "http://www.ncbi.nlm.nih.gov/pubmed/32661427"
  ],
  "snippets": [
    {
      "text": "new firefly bioluminescence substrates, and further evaluated their activities in vitro and in vivo. It is worth noting that the maximum biological emission wavelength of novel luciferin analogue AL3 ((S,E)-2-(6-hydroxy-5-(3-methoxy-3-oxoprop-1-en-1-yl)benzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylic acid) is 100 nm red-shifted compared with D-luciferin, ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35551298",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "AL4 ((S,E)-2-(5-(2-cyanovinyl)-6-hydroxybenzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylic acid) ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35551298",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The new substrate AL2 ((S,E)-2-(6-hydroxy-7-(3-methoxy-3-oxoprop-1-en-1-yl)benzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylic acid) showed better bioluminescence performance in vivo.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35551298",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The interaction of luciferases from two types of luminous bacteria, Photobacterium leiognathi and Vibrio harveyi, with their substrates [the photorecovered FMNH2 and long-chain aldehydes--decanal (C10), dodecanal (C12) and tetradecanal (C14)] ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/11512142",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Following coadministration of two luciferase substrates, native coelenterazine and luciferin,",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17994900",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Comparisons of experimental data with predictions based upon the three inhibitory models show that product inhibition during luciferase luminescence is noncompetitive with respect to both luciferin and ATP as substrates.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/836795",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "An alternative luciferase (Luc) substrate cyclic luciferin (Cycluc) was recently advanced for BLI applications as providing a stronger, more stable signal at significantly lower doses than the classical substrate D-luciferin (D-Luc) increasing sensitivity of Luc detection 10 to 100 times.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30979501",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ATP is one of the substrates of luciferase.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15165512",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "D-luciferin, a natural substrate of firefly luciferase, has been reported to have limited brain distribution, possibly due to the efflux transporter, breast cancer resistance protein (Bcrp), at the blood-brain barrier.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34887255",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "4-Methyl-D-luciferin is a substrate of Photinus pyralis luciferase, and it causes light emission in luminometric assays.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/2230665",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This study examined the pharmacokinetics, brain distribution, and the role of active efflux transporters on the luciferase substrates D-luciferin and CycLuc1.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34887255",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Antares, a fusion of the luciferase NanoLuc to the orange fluorescent protein CyOFP, has emerged as a bright bioluminescent reporter with orthogonal substrate specificity to firefly luciferase (FLuc) and its derivatives such as AkaLuc.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32661427",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Here we report cost-effective and efficient syntheses of d-luciferin and 6'-aminoluciferin, two widely used bioluminescent substrates.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25525906",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "d-Luciferin is a popular bioluminescent substrate of luciferase in the presence of ATP.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31764924",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "cusing on the tissue distribution of two luciferase substrates, D-luciferin and CycLuc1. D-luciferin, a natural substrate of firefly luciferase, has b",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34887255",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " non-competitive manner with respect to the luciferase substrates D-luciferin and ATP. By contrast, the compound has no effect on Renilla and Gaussia ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22789175",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "non-competitive manner with respect to the luciferase substrates D-luciferin and ATP. By contrast, the compound has no effect on Renilla and Gaussia l",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22789175",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "luciferin, coelenterazine (CTZ, AL3 ((S,E)-2-(6-hydroxy-5-(3-methoxy-3-oxoprop-1-en-1-yl)benzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylic acid), AL4 ((S,E)-2-(5-(2-cyanovinyl)-6-hydroxybenzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylic acid), AL2 ((S,E)-2-(6-hydroxy-7-(3-methoxy-3-oxoprop-1-en-1-yl)benzo[d]thiazol-2-yl)-4,5-dihydrothiazole-4-carboxylic acid), FMNH2, Decanal, long chain aldehydes, dodecanal, tetradecanal"
}